Cancer Communications >

2024 , Vol. 44 >Issue 5: 593 - 597

DOI: https://doi.org/10.1002/cac2.12526

Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study

  • Anna Jansana 1 ,
  • Aviane Auguste 2 ,
  • Marina Kvaskoff 2 ,
  • Agnès Fournier 2 ,
  • Emma Fontvieille 1 ,
  • Laia Peruchet-Noray 1 ,
  • Carine Biessy 1 ,
  • Reynalda Cordova 1,3 ,
  • Kristina Elin Nielsen Petersen 4 ,
  • Anne Tjønneland 4,5 ,
  • Verena Katzke 6 ,
  • Rudolf Kaaks 6 ,
  • Fulvio Ricceri 7,8 ,
  • Salvatore Panico 9 ,
  • Paolo Contiero 10 ,
  • Maria-Jose Sánchez 11,12 ,
  • Jesus Castilla 12,13 ,
  • Marta Crous-Bou 14,15 ,
  • Alicia Heath 16 ,
  • Elom Kouassivi Aglago 16 ,
  • Elisabete Weiderpass 1 ,
  • Marc James Gunter 1,16 ,
  • Pietro Ferrari 1 ,
  • Elio Riboli 16 ,
  • Vivian Viallon 1 ,
  • Heinz Freisling , 1
Expand
  • 1. International Agency for Research on Cancer (IARC-WHO), Lyon, France
  • 2. Paris-Saclay University, University of Versailles-Saint-Quentin-en-Yveline, University Paris-Sud, French National Institute for Health and Medical Research (Inserm), Gustave Roussy, “Exposome and Heredity” Team, CESP, Villejuif, France
  • 3. Department of Nutritional Sciences, University of Vienna, Vienna, Austria
  • 4. Danish Cancer Society Research Center, Copenhagen, Denmark
  • 5. Department of Public Health, University of Copenhagen, Copenhagen, Denmark
  • 6. Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany
  • 7. Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
  • 8. Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Turin, Italy
  • 9. Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy
  • 10. Environmental Epidemiology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Istituto Nazionale dei Tumori, Milan, Italy
  • 11. Cancer Registry of Granada, Institute for Biosanitary Research of Granada (ibs.GRANADA), Granada, Spain
  • 12. Epidemiology and Control of Chronic Diseases Group, Epidemiology and Public Health Networking Biomedical Research Centre, Madrid, Spain
  • 13. Navarra Public Health Institute, Pamplona, Spain
  • 14. Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain
  • 15. Department of Epidemiology, Harvard Tseng-Hsi Chan School of Public Health, Boston, Massachusetts, USA
  • 16. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK
freislingh@iarc.who.int

Received date: 17 May 2023

Revised date: 19 Dec 2023

Accepted date: 08 Feb 2024

Published date: 20 May 2024

Copyright

2024 2024 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd on behalf of Sun Yat-sen University Cancer Center.
Fold

Cite this article

Anna Jansana , Aviane Auguste , Marina Kvaskoff , Agnès Fournier , Emma Fontvieille , Laia Peruchet-Noray , Carine Biessy , Reynalda Cordova , Kristina Elin Nielsen Petersen , Anne Tjønneland , Verena Katzke , Rudolf Kaaks , Fulvio Ricceri , Salvatore Panico , Paolo Contiero , Maria-Jose Sánchez , Jesus Castilla , Marta Crous-Bou , Alicia Heath , Elom Kouassivi Aglago , Elisabete Weiderpass , Marc James Gunter , Pietro Ferrari , Elio Riboli , Vivian Viallon , Heinz Freisling . Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study[J]. Cancer Communications, 2024 , 44(5) : 593 -597 . DOI: 10.1002/cac2.12526

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Renzi C, Kaushal A, Emery J, Hamilton W, Neal RD, Rachet B, et al. Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms. Nat Rev Clin Oncol. 2019;16(12):746–61.

2
Sattar N, Gill JMR, Alazawi W. Improving prevention strategies for cardiometabolic disease. Nat Med. 2020;26(3):320–5.

3
Zaborowski AM, Abdile A, Adamina M, Aigner F, d'Allens L, Allmer C, et al. Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. JAMA Surg. 2021;156(9):865–74.

4
Mobley LR, Tangka FKL, Berkowitz Z, Miller J, Hall IJ, Wu M, Sabatino SA. Geographic Disparities in Late-Stage Breast Cancer Diagnosis Rates and Their Persistence Over Time. J Womens Health (Larchmt). 2021;30(6):807–15.

5
Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–50.

6
Gabler M, Geier S, Mayerhoff L, Rathmann W. Cardiovascular disease prevalence in type 2 diabetes - an analysis of a large German statutory health insurance database. BMC Public Health. 2021;21(1):328.

7
Boakye D, Günther K, Niedermaier T, Haug U, Ahrens W, Nagrani R. Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: A systematic review and meta-analysis. Cancer Epidemiol. 2021;75:102054.

8
Qiang JK, Sutradhar R, Giannakeas V, Bhatia D, Singh S, Lipscombe LL. Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study. Diabetologia. 2020;63(5):944–53.

9
von Wagner C, Cadar D, Hackett RA, Demakakos P, Beeken RJ, Cooper Bailey S, et al. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. J Med Screen. 2020;27(1):25–30.

10
Li P, Hu Y, Scelo G, Myrskylä M, Martikainen P. Pre-existing psychological disorders, diabetes, and pancreatic cancer: A population-based study of 38,952 Finns. Cancer Epidemiol. 2023;82:102307.

Options
Outlines

/

〈 〉